New hope for aggressive brain cancer: experimental therapy VRT106 enters human trials
NCT ID NCT07093814
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tests a new drug, VRT106, in 42 adults with glioblastoma that has come back or worsened. The goal is to see if it is safe and can shrink tumors or help people live longer. Participants receive the drug by injection, and doctors monitor side effects and how well it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, Guangxi, China
Contact Phone: •••-•••-••••
Contact
-
Nanfang Hospital, Southern Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Qilu Hospital of Shandong University
NOT_YET_RECRUITINGJinan, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Sanbo Brain Hospital Capital Medical University
NOT_YET_RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shenzhen Second People's Hospital
RECRUITINGShenzhen, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Tangdu Hospital of Air Force Medical University of the PLA
NOT_YET_RECRUITINGXi’an, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Cancer Hospital Affiliated to Chongqing University
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Fifth Affiliated Hospital of Sun Yat-sen University
RECRUITINGZhuhai, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
The First Affiliated Hospital of USTC
NOT_YET_RECRUITINGHefei, Anhui, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.